BRCA1/2 mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling.
Angel ChaoYi Hao LinLan-Yan YangRen-Chin WuWei Yang ChangPi Yueh ChangShih Cheng ChangChiao Yun LinHuei Jean HuangCheng-Tao LinHung Hsueh ChouKuan-Gen HuangWen Ling KuoTing Chang ChangChyong-Huey LaiPublished in: Journal of gynecologic oncology (2019)
Our results provide pilot evidence that BRCA1/2 mutations are common in Taiwanese patients with metachronous breast and ovarian malignancies, supporting the clinical utility of genetic counseling.